← FDA DRUG APPROVALS

FDA ANDA · ANDA091292

ANTI DIARRHEAL

loperamide hcl

Sponsor: PERRIGO R AND D

APPLICATION
ANDA091292
TYPE
ANDA
ORIGINAL APPROVAL
2011-05-20
LATEST ACTION
2021-12-13
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Over-the-counter

Products

LOPERAMIDE HYDROCHLORIDEOver-the-counter
LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML · SOLUTION · ORAL

Approval history

2021-12-13Labeling · Supplement 16 · standardAP
2021-12-13Labeling · Supplement 12 · standardAP
2015-11-30Labeling · Supplement 3 · standardAP
2015-11-30Labeling · Supplement 8 · standardAP
2011-05-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →